Grade My Investments
HomeFree Stock Grades › SIBN

SI-BONE, Inc. (SIBN) Stock Grade

SIBN · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$858.0M
P/E Ratio
Revenue Growth (YoY)
+20.2%
Net Margin
-9.4%
Return on Equity
Dividend Yield
None

About SI-BONE, Inc.'s fundamentals

SI-BONE is a medical devices company with a market capitalization of $858.0 million that is currently unprofitable, reporting a net loss in its latest annual statement and a negative net margin of -9.4%. However, the company is experiencing strong revenue growth of 20.2% year-over-year, suggesting expansion in its market presence despite ongoing losses. With no dividend and negative profitability metrics, SI-BONE appears to be in a growth-investment phase where it is prioritizing revenue expansion while managing operational costs.

Track SIBN free — no credit card required. Live grade + monthly AI report →